Axsome Therapeutics
AXSM
AXSM
109 hedge funds and large institutions have $476M invested in Axsome Therapeutics in 2019 Q2 according to their latest regulatory filings, with 57 funds opening new positions, 25 increasing their positions, 20 reducing their positions, and 13 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
109
Holders Change
+44
Holders Change %
+67.69%
% of All Funds
2.37%
Holding in Top 10
6
Holding in Top 10 Change
+4
Holding in Top 10 Change %
+200%
% of All Funds
0.13%
New
57
Increased
25
Reduced
20
Closed
13
Calls
$28.5M
Puts
$10.9M
Net Calls
+$17.6M
Net Calls Change
+$988K
Top Buyers
| 1 |
1
BlackRock
New York
|
$43.5M |
| 2 |
2
AllianceBernstein
Nashville,
Tennessee
|
$19.9M |
| 3 |
3
State Street
Boston,
Massachusetts
|
$16.8M |
| 4 |
4
T. Rowe Price Associates
Baltimore,
Maryland
|
$14.9M |
| 5 |
VMI
5
VHCP Management III
New York
|
$41.5M |
Top Sellers
| 1 |
RCM
1
RA Capital Management
Boston,
Massachusetts
|
$34.5M |
| 2 |
BBA
2
Baker Bros. Advisors
New York
|
$19.9M |
| 3 |
3
Millennium Management
New York
|
$10M |
| 4 |
4
Invesco
Atlanta,
Georgia
|
$20.8M |
| 5 |
PVI
5
Pura Vida Investments
New York
|
$201K |
